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ABSTRACT 
A highly efficient and environmentally benign for the synthesis a of 2-amino-7-hydroxy-4-aryl-4H-chromene-3-carbonitrile derivatives (4a-n) 
in good to high yields (90%-97%) by one-pot three-component Michael addition reaction of malononitrile, aromatic aldehydes and resorcinol 
under reflux condition was developed in aqueous medium. Single crystal X-ray studies show that 4h crystallizes in the formula C22H15Cl2N2O2, 
Mr=410.26, Monoclinic, Space group P2(1)/c, a=12.753(9)Å, b=6.665(4)Å, c=24.050(14) Å, β=102.95(3)A° and 4i C16H10Cl2N2O2, Mr=333.16, 
Triclinic, Space group P-1, a=6.271(3)Å, b=18.697(5)Å, c =13.794(7) Å, β =94.269(17)A°. The structure of the products were further confirmed 
by 1H NMR, 13C NMR, IR and Mass spectrum. 
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INTRODUCTION 
Pyran  (chromene or benzo Pyran)  is an oxygen-containing 
heterocyclic moiety, which is attracted great significance due 
to their medicinal application. The pyran ring is the core unit 
of  benzopyran, chromone, flavanoids, coumarin etc., which 
exhibit different pharmacological activities. Pyran 
heterocycles are both prevalent across compounds classified 
as of ‘natural origin’ and ‘man-made’. Numerous naturally 
occurring compounds containing pyrans and benzopyrans, 
show attractive therapeutic activities. The classification of 
pyran heterocyclic compounds depends on the presence of 
the 2H or 4H- pyran scaffold (Fig. 1). Thus, the benzo 
derivative of 2H-pyran is called 4H-1-benzopyran 
(commonly 4H-chromene)named and the benzo analogue of 
4H-pyran is 2H-1-benzopyran (commonly 2H-chromene).[1] 
The parent molecules being pyran- 2-one and pyran-4-one. 
Paltry names are utilized for the related benzo analogues; 
coumarin, dihydrocoumarin, chromone. The diverse 
anticancer capabilities of pyrans have been additionally 
evidenced by the fact that this heterocycle has recently been 
a focal point for researchers worldwide.[2]. 
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Figure 1: Pyran-based heterocycles 
Multi-component reactions (MCRs) have been successfully 
employed to generate highly diverse combinatorial libraries 
for high-throughput medicinal chemistry. In addition, use of 
water for the organic reactions has been an important and 
fertile area of research in recent years. The usefulness of 
MCR is even greater when they provide access to “privileged 
medicinal scaffolds”. One such significant scaffold is the 
pyran nucleus which is the key constituent of a wide range of 
both natural and synthetic bioactive compounds. The  
compounds containing 4H-chromene scaffold have found 
other applications such as optical brighteners, [3] 
fluorescence markers, [4] pigments, [5] cosmetics, 
biodegradable agrochemicals, [6] mutagenicity, [7] sex 
pheromone, [8] laser dyes, [9] central nervous system 
activity, [10] and pH sensitive fluorescent materials for 
visualization of biomolecules.[11] Moreover, 7-Hydroxy-6-
methoxy-4H-chromene A (Fig. 2) is an example of naturally 
occurring 4H-chromene, which was obtained from the 
flowers of Wisteria sinensis and is one of their fragrance 
components.[12] Among different types of chromene 
systems, 2-Amino-4H-chromenes have been reported to 
exhibit highly useful proapoptotic properties for the 
treatment of a wide range of cancer ailments.[13] In cancer 
chemotherapy, 2-Amino-4H-chromene B was marked for 
drug development due to its high inhibition of tumor-
associated Bcl-2 proteins.[14] A modified 4H-chromene 
structure C was able to induce apoptosis (programmed cell 
death) in several cancer cell lines.[15] 
In particular, 2-Amino-4H-chromene derivatives are of 
recent interest for their antitumor activities.[16] In addition, 
4H-chromene derivatives observed some biological and 
pharmacological effects such as treatment of advanced solid 
tumors, [17] blood anticoagulant warfarin, [18] anticancer 
therapeutic, [19] inhibitor of Bcl-2 protein and apoptosis 
inducer.[20] Multi-component reactions (MCRs) have been 
successfully employed to generate highly diverse 
combinatorial libraries for high-throughput screening of 
biological and pharmacological activities.[21] 
A variety of natural and synthetic derivatives of chromene 
have important biological and pharmacological applications, 
such as antimicrobial, [22] anti-inflammatory, [23] 
antiproliferative, [24] antioxidant, [25] herbicidal, analgesic 
and anticonvulsant, [26] antitubercular,[27] anticoagulant, 
estrogenic antispasmolytic, estrogenic, [28-37]   TNF-α 
inhibitor effects and activities, [38]   as well as inhibitor of 
diabetes-induced vascular dysfunction.[39,40] Such diverse 
biological and pharmacological activities have made 
chromene derivatives important for further development in 
medicinal and organic synthesis studies.[41]. 
 
 
Figure 2: Structure of some biologically important 2-Amino-3-cyano-4H-chromenes 
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The field of organic synthesis has recently experienced 
numerous innovative scientific breakthroughs accompanied 
by improved and efficient synthetic protocols that avoid the 
use of toxic reagents. Rather than being a discipline itself, 
Green chemistry encompasses a series of considerations in 
the design of environmentally benign protocols comprising 
subjects such as energy consumption, atom efficiency, and 
sustainability of chemical processes. A major point in the 
design of greener and more sustainable processes relates to 
the efficiency of the process, which has to take into account 
several parameters including energy, material consumption 
(preferably use of bio renewable resources), man-power 
(automation), and reactor usage (e.g. flow versus batch 
reactions). Concepts such as ‘‘atom-economy’’[41] and 
efforts towards minimization of auxiliary chemicals (which 
include protection–deprotection sequences and use of 
volatile organic solvents) form the pillars of material 
efficiency in chemical production. In chemical reactions, 
solvents play a very important role in extractions, reactants 
solubility, washing, and separation of final products. For the 
past two decades, scientists have devoted a great deal of 
research effort to replace toxic and harmful solvents by 
more environmentally benign alternatives.[2] Water is 
among the most widely explored greener alternatives in 
recent years. 
In general water is considered a ‘‘green solvent’’ for organic 
reactions; though, chemical reactions performed ‘‘in- or on-
water’’ are not generally considered as greener reactions 
and often do not meet the requirements of ideal green 
processes. The aim of this work is to provide a 
comprehensive overview of the most promising, alternative 
greener methodologies that can be employed in organic 
synthesis with the purpose of designing safer, more benign 
as well as low environmental impact processes, which can 
lead to improved efficiencies for industrial applications. In 
my research catalyst free synthesise of 2-Amino-3-cyano-
4H-benzopyran in aqueous medium based on multi-
component reaction. Naturally occurring  and man made 
benzopyrans derivatives have attracted great interest to 
researchers, because  their excellent biological and 
pharmacological properties (Fig.2 ). 
Organic reactions in aqueous media  
Early 1980s, the use of water as solvent for organic reaction 
was limited, although in 1931 the very first known example 
was reported by Diels and Alder for the cycloaddition 
reaction in water. In the 1980s Breslow can revisited The 
use of water as a solvent in organic chemistry, the rate of 
several organic reactions could strongly enhance by 
hydrophobic effects. Notably, in the exploration of new 
‘‘green’’ procedures, synthetic organic conversions was 
found to be useful in high temperature water (HTW). Water 
is the solvent of choice not only from an environmental 
standpoint but also from an economic point of view since it 
is cheap, non-flammable, and abundantly available. 
Compared with common organic solvents, the unique and 
unusual physical properties such as high specific heat, high 
surface tension, high dielectric constant, large cohesive 
energy density and chemical properties (ability to form 
hydrogen bonds and amphoteric nature) of water can in 
principle influence positively the reactivity and selectivity of 
chemical reactions (Fig. 3). 
The main advantages of using water are based on: 
 Its flexibility to form strong hydrogen bonds that give 
it a significant surface tension (three times that of 
liquid ammonia) – which could facilitate the 
aggregation of reactants. 
 Its ability to form weak non-covalent bonds with other 
compounds. 
 Its ability to engage in electron transport reactions as 
exemplified by many biological and synthetic reactions.
 
 
Figure 3: Chemical structure of water and its physical interactions with solute molecules Catalyst-free on-water 
organic reactions 
 
Recently, this concept was revisited by Sharpless and co-
workers with some representative reactions where water 
insoluble reactants are converted to products in high yields; 
the reaction mixture is usually stirred vigorously in water 
for a short period. The representative examples included 
cycloadditions, such as classic Diels–Alder reactions, as well 
as nucleophilic ring-opening of epoxides and aromatic 
Claisen rearrangements. Since the reactants were insoluble 
in water, the reactions were described as being on-water. 
Due to the aforementioned versatile and unique properties 
of water, rates and selectivities of pericyclic reactions under 
on-water conditions can be improved, as well as in a series 
of related organic transformations in the presence and/or 
absence of catalysts.  
Catalyst-free reactions in-water 
For Catalyst-free organic reactions water can be used as a 
better medium. Currently, organic reactions that are carried 
out in water are classified as on-water or in-water, 
depending on the solubility of chemical components. 
According to Breslow, in-water, the organic molecules are 
forced to form aggregates in order to decrease the exposed 
organic surface area. Due to these aggregates, holes are 
formed in the cluster structure of liquid water and the bulk 
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water molecules surround or hydrate the aggregates. In the 
final layer of the hydration shell, as the bulk water molecules 
approach the surface of small aggregates their H-bond links 
run laterally along the hydrophobic surface. This effect is 
known as the ‘‘Breslow hydrophobic effect’’. With large 
hydrophobic surfaces some dangling hydrogen bond (OH-
free) groups are orientated toward the barrier to maximize 
the packing density of the molecule. In the last few decades 
in-water reactions have been studied in detail, the main 
characteristics being: (a) hydrophobicity, which speeds up 
reactions; (b) hydrogen bonding, with impact on reactants 
and transition states which may or may not favor the 
hydrophobic effect; and (c) water polarity, which may again 
increase or decrease the reaction rates. 
Traditionally, we have achieved nucleophilic addition 
reaction to used alkali metal hydroxides, pyridine, and 
piperidine as catalysts by the reaction of active methylene to 
a carbonyl group followed by dehydration [Knoevenagel 
condensation]. Frequently some organic reaction reported 
an uncatalyzed tandem Knoevenagel condensation and 
Michael addition reactions are  performed in aqueous media. 
Organic synthesis can play a lead role in addition reactions, 
due to their importance in the preparation of key 
pharmaceutical intermediates and other compounds. 
Synthesis of benzopyrans and their derivatives are 
important moieties in various pharmaceutical and chemical 
syntheses and have broad scope in biological activities such 
as antipyretics and analgesics, their synthesis is normally 
conducted using acid catalysts and expensive reagents. 
Vasuki and Kumaravel investigated the uncatalyzed 
synthesis of a combinatorial library of 2-Amino-4-(5-
hydroxy-3-methyl-1-Hpyrazol- 4-yl)-4H-chromene-3-
carbonitrile derivatives via a four component reaction 
between hydrazine hydrate, ethyl acetoacetate, 2-
hydroxybenzaldehydes, and malononitrile in-water at room 
temperature this multicomponent catalyst-free protocol in 
aqueous media is highly atom economic with ethanol and 
water being the only byproduct of the reaction. Recent two 
decade plenty of methods have been followed by the 
syntheses 4H- pyran and its derivatives.[41]  
RESULT AND DISCUSSION 
First we examined the multicomponent domino reaction of 
malononitrile, aryl aldehyde and resorcinol was chosen as 
the model reaction. The effect of various reaction 
parameters such as the influence of solvent, formation of 
hydrogen bond and the effect of temperature were studied 
to optimize the reaction conditions (Table 1). It is important 
to note that K2CO3 and Na2CO3 was found to be the catalyst 
for the three component reaction of malanonitrile, aryl 
aldehyde and resorcinol affording a considerable yield of the 
desired product. Moreover in the absence of catalyst a 
significant product formation was observed under reflux 
condition (Table 1, entry 14). 
The solvent temperature plays an important role in the 
reactivity (Table 1). We have investigated the effect of 
various protic, aprotic and non-polar solvents on the three 
component reaction of resorcinol, aryl aldehyde and 
malononitrile (Table 1, entry 1-14). In non-polar solvents 
such as 1,4-dioxane and Toluene, the yield of the reaction 
was found to be very low (10-20%) (Table 1, entry 
5,6,11,12). Whereas in the case of polar aprotic solvents 
such as THF, acetonitrile, the yield of the reaction was found 
to be low (8-15%) (Table 1, entry 3,4,9,10). In the case of 
polar protic solvents such as ethanol and methanol (Table 1, 
entry 1,2,7,8), the yield of the desired product was 
considerable (50-65%). Further increase in the reaction 
temperature to reflux makes the reaction almost 
quantitative (Table 1, entry 14). From Table 1, it is clear that 
water was the best choice as solvent. 
We examined the substrate scope of substituted 
benzaldehydes (2a-2n) under optimized reaction condition 
for the synthesis of chromene derivatives (4a-4n). All the 
electron donating and electron withdrawing aldehydes are 
compatible with optimized reaction condition afforded the 
excellent yield 80-93%. 
 
Table 1  Optimization of reaction conditions 
Entry Base 
 
Solvent 
 
Temp (oC) Time 
(min) 
Yield 4a 
(%) 
  1 Na2CO3  EtOH 60 30 50 
2 " MeOH 50 30 55 
3 " THF 50 30 10 
4 "  Acetonitrile 60 30 8 
5 " Dioxane 60 30 15 
6 " Toluene 80 30 10 
7 K2CO3 EtOH 60 30 60 
8 " MeOH 50 30 65 
9 " THF 50 30 15 
10 " Acetonitrile 60 30 10 
11 " Dioxane 60 30 20 
12 " Toluene 80 30 12 
13 - H2O 60 30 50 
14 - H2O reflux 15-20 80-93 
 
Chemistry 
2-Amino-3cyano-4H-benzopyrans (4a-n) was prepared via 
multi-component reaction, malononitrile (1) with 
substituted aromatic aldehydes (2) resorcinol (3) and in 
aqueous medium conditions for 15-20 min at 120°C as 
shown in (Scheme1). The assignment structures 4h and 4i 
were confirmed on the basis of spectral data and single 
crystal XRD method. The IR spectra of 4a-4n showed the 
appearance of the -OH stretch at 3476–3435 cm-1, -NH2 
stretch at 3348–3330, 3265–3210 cm-1 and -CN stretch at 
2199–2180 cm-1. The 1H and 13C NMR spectra of 4a-4n 
revealed the presence of 4H signals at  5.66–4.40 (s, 1H, H-
4), 56.05–35.00 ppm (C-4) and OH signals at  9.99–9.40 
ppm. In addition, the mass spectra of compounds 4h and 4i  
and X-ray diffraction  gave also additional evidences for 
established the proposed structures. 
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Structure of synthesised compounds(4a-4n) 
 
 
Table 2:   Synthesis of  2-Amino-3cyano-4H-benzopyran  in aqueous medium 
Entry 
R 
Molecular  
formula 
Molecular  
Weight 
Time 
(minute) 
Yield (%) m.p ˚C 
4a 2-CH3 C17H14N2O2 278 20 98 210 
4b 4-CH(CH3)2 C19H18N2O2 306 15 99 225 
4c 3-Cl C16H11ClN2O2 298 10 99 245 
4d 4-OC2H5 C18H16N2O3 308 15 95 230 
4e 2,4-OCH3 C18H16N2O4 324 10 92 210 
4f 4-F C16H11FN2O2 282 10 96 250 
4g 2-Cl,4-F C16H10ClFN2O2 316 20 90 210 
4h 3,4-Cl C16H10Cl2N2O2 332 10 99 244 
4i 2,6-Cl C16H10Cl2N2O2 332 10 99 262 
4j 3-Br C16H11BrN2O2 342 15 97 215 
4k 3-F C16H11FN2O2 282 16 96 218 
4l 2-F C16H11FN2O2 282 10 94 222 
4m 3-OCH3 C17H14N2O3 294 17 95 263 
4n 4-C2H5 C18H16N2O2 292 20 88 248 
 
The structure of 4h and 4i were confirmed by X-ray 
diffraction analysis, as shown in figures 4 and 5 respectively. 
The selected crystallographic data are listed in Table 3. The 
orientation of the benzopyran and chlorophenyl rings are 
confirmed from the torsion angle value [C5-C6-C7-C8 =    -
133.6(3º), C1-C6-C7-C8 =47.4(4º)]. In the benzopyran moiety, 
attached carbonitrile, amino and hydroxy groups lie in same 
plane. Empirical formula C22H15Cl2N2O2, Mr=410.26, 
Monoclinic, Space group P2(1)/c, a=12.753(9)Å, 
b=6.665(4)Å, c =24.050(14) Å, β=102.95(3)A°, V=1992(2) 
Å3, Z=4, Dcalc=1.368 mg/m3, F(000)=844, µ=0.346 mm-1, 
crystal dimension 0.150 x 0.150 x 0.100 mm3. Intensity data 
were collected at 294(K), λ=0.71073nm. A total of 34682 
reflection were collected with 3492 unique (Rint= 0.0334). 
The final R and WR values are 0.0671 and 0.2114 e.Å-3, 
S=1.080. The maximum peak and minimum peak in the final 
difference map are 0.718 and -0.637 e. Å-3. The sum of the 
bond angles around the atom N1 of the pyran ring is in 
accordance with sp2 hybridization state. 
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Figure 4: ORTEP diagram of compound 4h 
 
The orientation of the benzopyran and chlorophenyl ring  in 
molecule 4i is confirmed from the torsion angle value [C8-C7-
C6-C5 = -54.0(2º), C8-C7-C6-C1 =128.47(17º)]. In the 
benzopyran moiety, attached amino carbonitrile and 
hydroxy groups lie in same plane. Empirical formula 
C16H10Cl2N2O2, Mr=333.16, Triclinic, Space group P-1, 
a=6.271(3)Å, b=18.697(5)Å,                   c=13.794(7) Å, 
β=94.269(17)A°, V=712(7) Å3, Z=2, Dcalc=1.553 mg/m3, 
F(000)=340, µ=0.643 mm-1, crystal dimension 0.150 x 0.150 
x 0.100 mm3. Intensity data were collected at 294 K 
λ=0.71073nm. A total of 22289 reflection were collected 
with 2499 unique (Rint= 0.0226). The final R and WR values 
are 0.0336 and 0.0868,  S=1.130.The maximum peak and 
minimum peak in the final difference map are 0.226 and -
0.272 e. Å-3. The sum of the bond angles around atom N1 of 
the pyran ring is in accordance with sp2 hybridization 
state[360].
 
 
Figure 5: ORTEP diagram of compound 4i             
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A sequentional reaction of Knoevenagal condensation and Michael-addition followed the intramolecular cyclization may take 
place during the formation of the product. The possible mechanism is shown in scheme 1. 
 
 
 
Table 3:  Crystallographic data for 4h and 4i 
Compound 4h 4i 
Identification code 
 Empirical formula  
Formula weight  
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
 
 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(000)  
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta =  
Absorption correction 
Max. and min. transmission 0.7461 and 0.7041 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
mrb21  
C22 H15 Cl2 N2 O2 
410.26 
294(2) K 
0.71073 Å 
Monoclinic 
P21/c 
a = 12.753(9) Å, a= 90°. 
b = 6.665(4) Å, b= 102.95(3)° 
c = 24.050(14) Å, g = 90°. 
1992(2) Å3 
4 
1.368 Mg/m3 
0.346 mm-1 
844 
0.150 x 0.150 x 0.100 mm3 
3.178 to 24.998°. 
-15<=h<=15, -7<=k<=7, -28<=l<=26 
34682 
3492 [R(int) = 0.0334] 
24.998°,  99.7 %    
Semi-empirical from equivalents 
0.7454 and 0.7035 
Full-matrix least-squares on F2 
3492 / 0 / 253 
1.080 
R1 = 0.0671, wR2 = 0.1949 
R1 = 0.0803, wR2 = 0.2114 
0.718 and -0.637 e.Å-3 
mrb22  
C16 H10 Cl2 N2 O2 
333.16 
294(2) K 
0.71073 Å 
Triclinic 
P-1 
a = 6.271(3) Å, a= 107.06(2)°. 
b = 8.697(5) Å, b= 94.269(17)°. 
c = 13.794(7) Å, g = 95.00(3)°. 
712.5(7) Å3 
2 
1.553 Mg/m3 
0.463 mm-1 
340 
0.150 x 0.150 x 0.100 mm3 
3.872 to 25.000°. 
-7<=h<=7, -10<=k<=10, -16<=l<=16 
22289 
2499 [R(int) = 0.0226]  
25.000°,  98.9 %   
Semi-empirical from equivalents 
0.7461 and 0.7041 
Full-matrix least-squares on F2 
2499 / 0 / 211 
1.130 
R1 = 0.0336, wR2 = 0.0795 
R1 = 0.0392, wR2 = 0.0868 
0.226 and -0.272 e.Å-3 
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Experimental  
All the chemicals used were purchased from Merck AnalaR 
grade and purified wherever necessary using the standard 
purification method. The purity of compounds were checked 
by TLC using silica gel-G plate and visualized by iodine 
vapours The melting points were recorded in open capillary 
tube and uncorrected. The FT-IR spectra were recorded in 
SHIMADZU FT-IR Affinity-I spectrometer using KBr pellets 
and perkinealmer . The 1H-NMR and 13C-NMR spectra were 
obtained in DMSO-d6 on BRUKER 300 MHZ and 500MHZ 
instrument with TMS as an internal standard and the 
chemical shift values are presented in ppm. The mass 
spectra were taken on SHIMADZU GC-MS QP 2010 
spectrometer operating at an ionization potential of 70ev.  
Synthesis of 2-Amino-7-hydroxy-4-(substituted 
benzaldehyde)-4H-chromene-3-carbonitrile ( 4a-n) 
 To a stirred solution of benzoldehyde in a water was added 
resorcinol and malononitrile at room temperature  and 
reflexed for 15 - 20 minutes. The progress of the reaction 
was monitored by thin layer chromatography using silica 
gel-G plates.  The reaction mixture was cooled. The 
precipitated solid was filtered at suction pump. The crude 
solid obtained was recrystalized by methanol. 
2-Amino-7-hydroxy-4-(o-tolyl)-4H-chromene-3-
carbonitrile 4a 
IR: (KBr cm-1) 3421 (OH), 3337, 3220 (NH2), 3070(CH-Ar), 
2922 (CH-Aliphatic), 2193 (CN), 1653 (C=C) 1461 (C=C), 
1110 (C-O-C), 1301 (C-N), 1H NMR (300 MHz DMSO –d6): H 
2.33 (S, 3H, CH3), 4.93 (S, 1H m H-4), 6.47 (d, 1H, J=2.1 Hz, 
Ar-H), 6.48-6.52 (dd, 1H, J=2.4, 6 Hz, Ar-H), 6.65(d, 1H, J= 
8.4, Ar-H), 6.84 (S, 2H, NH2), 6.99 (d, 1H,  J= 7.2 Hz, Ar-H), 
7.06-7.14 (m, 3H, Ar-H), 9.75 (s, H, OH). 13C NMR (500 MHz 
DMSO d6), c 19.01, 56.08, 102.06, 112.42, 113.46, 120.62, 
126.62, 126.36, 126.50, 129.21, 129.68, 130.67, 134.84, 
143.99, 149.07, 157.05, 159.93.  
2-Amino-7-hydroxy-4-(4-isopropylphenyl)-4H-
chromene-3-carbonitrile 4b 
IR: (KBr cm-1) 3485 (OH), 3344, 3264 (NH2), 3070(CH-Ar), 
2961 (CH-Aliphatic), 2194 (CN), 1644 (C=C) 1462(C=C), 
1343 (C-N),1154 (C-C), 1110 (C-O-C).H1 NMR (500 MHz 
DMSO –d6): H1.15 (d,6H, J=9 Hz, CH3), 2.79-2.84 (m, 1H, Ali-
H), 4.56 (s, 1H, H-4), 6.79 (d, 1H, J=8.5 Hz, Ar-H), 6.84 (s, 2H, 
NH2), 7.05 (d, 2H, J=8 Hz, Ar-H), 9.71 (s, 1H, OH).13C NMR 
(500 MHz DMSO d6), c 24.33, 33.48, 56.80, 102.61, 112.82, 
114.40, 121.26, 126.95, 127.66, 130.37, 144.32, 147.07, 
149.30, 157.48, 160.71. 
2-Amino-4-(3-chlorophenyl)-7-hydroxy-4H-chromene-
3-carbonitrile 4c 
IR: (KBr cm-1) 3477 (OH), 3344, 3244 (NH2), 2924(CH-Ar), 
2890 (CH-Aliphatic), 2194 (CN), 1637 (C=C) 1457(C=C), 
1346 (C-N),1151 (C-C),  1101 (C-O-C). H1 NMR (300 MHz 
DMSO –d6): H4.69(s,1H, H-4), 6.41 (d, 1H, J=2.4 Hz, Ar-H), 
6.48-6.52 (dd, 1H, J=2.4, 6.0 Hz, Ar-H), 6.81 (d, 1H, J=8.7 Hz, 
Ar-H), 6.97 (s, 2H, NH2), 7.13(d, 1H,  J=6 Hz,Ar-H), 7.20-7.21 
(t, 1H, J= 1.8 Hz, Ar-H), 7.26-7.32 (m, 2H, Ar-H), 9.76 (s, 1H, 
OH). 13C NMR (500 MHz DMSO d6), c 24.33, 33.48, 56.80, 
102.61, 112.82, 114.40, 121.26, 126.95, 127.66, 130.37, 
144.32, 147.07, 149.30, 157.48, 160.71.  
2-Amino-4-(4-ethoxyphenyl)-7-hydroxy-4H-chromene-
3-carbonitrile 4d 
IR: (KBr cm-1) 3428 (OH), 3333, 3220 (NH2), 3073 (CH-Ar), 
2989 (CH-Aliphatic), 2193 (CN), 1659 (C=C) 1466 (C=C), 
1339 (C-N), 1156 (C-C), 1111 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H1.26 (t, 3H, J=7 Hz, CH3), 3.92-3.97 (q,2H, J=7.7 
Hz, CH2), 4.55 (s, 1H, H-4), 6.42 (d, 1H, J=2, Ar-H), 6.48-6.50 
(dd, 1H, J= 2.5, 6 Hz, Ar-H), 6.77 (d, 1H, J=8.5, Ar-H), 6.82 (d, 
1H, J= 1.0 Hz, Ar-H), 6.84 (s, 2H, , NH2), 7.05 (d, 2H, J=9.0 Hz, 
Ar-H), 9.72 (s, 1H, OH), 13C NMR (500 MHz DMSO d6), 
c15.05, 57.09, 63.39, 102.60, 112.81, 114.56, 114.82, 
121.24, 128.88, 130.39, 130.62, 138.81, 149.24, 157.43, 
160.58.  
2-Amino-4-(2,4-dimethoxyphenyl)-7-hydroxy-4H-
chromene-3-carbonitrile 4e 
IR: (KBr cm-1) 3418 (OH), 3329, 3218 (NH2), 3029 (CH-Ar), 
2942 (CH-Aliphatic), 2197 (CN), 1644 (C=C) 1456 (C=C), 
1377 (C-N), 1154 (C-C), 1112 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H3.71 (s, 3H, OCH3), 3.76 (s, 3H, OCH3),4.87 (s, 
1H, H-4), 6.36 (d, 1H, J=2.5, Ar-H), 6.43-6.46 (m, 2H, Ar-H), 
6.53 (d, 1H, J=2, Ar-H), 6.74 (s, 2H, NH2) 6.79 (d, 1H, J=8.5 Hz, 
Ar-H), 9.63 (s, 1H, OH), 13C NMR (500 MHz DMSO 
d6),c55.10, 55.90, 56.19, 102.47, 105.65, 105.93, 112.59, 
114.78, 115.75, 121.32, 126.94, 129.68, 131.18, 157.20, 
159.69, 161.43, 162.74, 166.02.  
2-Amino-4-(4-fluorophenyl)-7-hydroxy-4H-chromene-3-
carbonitrile 4f 
IR: (KBr cm-1) 3429 (OH), 3340, 3279 (NH2), 3043 (CH-Ar), 
2882 (CH-Aliphatic), 2184 (CN), 1643 (C=C) 1457 (C=C), 
1331 (C-N), 1152 (C-C), 1110 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H4.66 (s, 1H, H-4), 6.4 (d, 1H, J=2.5, Ar-H), 6.48-
6.50 (dd, 1H, J= 2.5, 6 Hz, Ar-H), 6.77 (d, 1H, J=8.5 Hz, Ar-H), 
6.88 (s, 2H, NH2) 7.10-7.14 (t, 2H, J=9 Hz, Ar-H), 7.18-7.21 (q, 
2H, J= 5.5, 3 Hz, Ar-H), 9.70 (s, 1H, OH), 13C NMR (500 MHz 
DMSO d6), c56.66, 102.67, 112.91, 114.01, 115.67, 115.67, 
115.84, 121.02, 129.67, 129.67, 129.74, 130.36, 149.28, 
157.61, 160.46, 160.46, 160.66, 162.39.  
2-Amino-4-(2-chloro-6-fluorophenyl)-7-hydroxy-4H-
chromene-3-carbonitrile 4g 
IR: (KBr cm-1) 3421 (OH), 3327, 3220 (NH2), 3081 (CH-Ar), 
2937 (CH-Aliphatic), 2196 (CN), 1653 (C=C) 1454 (C=C), 
1350 (C-N), 1149 (C-C), 1111 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H5.34 (s, 1H, H-4), 6.40 (d, 1H, J=2.5 Hz, Ar-H), 
6.47-6.49 (dd, 1H, J= 2, 6.5 Hz, Ar-H), 6.68 (d, 1H, J= 3.5 Hz, 
Ar-H) 6.93 (s, 2H, NH2), 7.15 (s, 1H, Ar-H), 7.31-7.34 (t, 2H, 
J= 6.5 Hz, Ar-H), 9.74 (s, 1H, OH).13C NMR (500 MHz DMSO 
d6),c53.08, 102.61, 115.15, 112.78, 115.79, 120.66, 126.66, 
126.23, 129.24, 130.05, 130.13, 133.70, 157.94, 161.14, 
162.87.  
2-Amino-4-(3,4-dichlorophenyl)-7-hydroxy-4H-
chromene-3-carbonitrile 4h 
IR: (KBr cm-1) 3478 (OH), 3342, 3267 (NH2), 3080 (CH-Ar), 
2933 (CH-Aliphatic), 2192 (CN), 1640 (C=C) 1467 (C=C), 
1347 (C-N), 1154 (C-C), 1112 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H4.72 (s, 1H, H-4), 6.41 (d, 1H, J=2 Hz, Ar-H), 
6.49-6.51 (dd, 1H, J= 2.5, 6 Hz, Ar-H), 6.80 (d, 1H, J= 8.5 Hz, 
Ar-H) 7.00 (s, 2H, NH2), 7.13-7.15 (dd, 1H, J= 2, 6.5 Hz, Ar-H), 
7.43 (d, 1H, J= 2 Hz, Ar-H), 7.5 (d, 1H, J= 8.5 Hz Ar-H), 9.80 (s, 
1H, OH).13C NMR (500 MHz DMSO d6),c55.70, 102.78, 
113.00, 113.08, 120.87, 128.38, 129.75, 129.78, 130.40, 
131.45, 131.53, 147.90, 149.25, 157.85, 160.83.  
2-Amino-4-(2,6-dichlorophenyl)-7-hydroxy-4H-
chromene-3-carbonitrile 4i 
IR: (KBr cm-1) 3481 (OH), 3339, 3260 (NH2), 3081 (CH-Ar), 
2926 (CH-Aliphatic), 2190 (CN), 1641 (C=C) 1462 (C=C), 
1339 (C-N), 1155 (C-C), 1112 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H5.69 (s, 1H, H-4), 6.37 (d, 1H, J= 2.5 Hz, Ar-H), 
6.45-6.47 (dd, 1H, J= 2.5, 6 Hz, Ar- H), 6.57 (d, 1H, J= 8.5, Ar-
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H), 6.93 (s, 2H, NH2), 7.28-7.31 (t, 1H, J= 8 Hz, Ar-H), 7.35 (d, 
1H, J= 7.5 Hz), 7.52 (d, 1H, J= 8 Hz, Ar-H), 9.73 (s, 1H, OH).13C 
NMR (500 MHz DMSO d6),c52.65, 102.49, 110.56, 112.73, 
120.46, 128.86, 128.95, 130.05, 131.19, 135.79, 138.38, 
150.08, 157.97, 161.22.  
2-Amino-4-(3-bromophenyl)-7-hydroxy-4H-chromene-
3-carbonitrile 4j 
IR: (KBr cm-1) 3435 (OH), 3338, 3217 (NH2), 3076 (CH-Ar), 
2937 (CH-Aliphatic), 2194 (CN), 1649 (C=C) 1466 (C=C), 
1317 (C-N), 1157 (C-C), 1114 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H4.68 (s, 1H, H-4), 6.4 (d, 1H, J= 2.4 Hz, Ar-H), 
6.49-6.52 (dd, 1H, J= 2.4, 6 Hz, Ar-H), 6.81 (d, 1H, J= 8.7 Hz), 
6.98 (s, 2H, NH2), 7.17-7.20 (m, 1H, Ar-H),  7.26-7.31 (t, 1H, 
J= 7.8 Hz, Ar-H), 7.34-7.35 (t, 1H, J= 1.8 Hz, Ar-H), 7.40-7.43 
(m, 1H, Ar-H), 9.77 (s, 1H, OH).13C NMR (300 MHz DMSO 
d6),c55.64, 1012.26, 112.53, 112.94, 120. 46, 121.83, 
126.55, 129.57, 129.88, 129.95, 130.86, 148.79, 149.07, 
157.27, 160.33.  
2-Amino-4-(3-fluorophenyl)-7-hydroxy-4H-chromene-3-
carbonitrile 4k 
IR: (KBr cm-1) 3435 (OH), 3338, 3217 (NH2), 3076 (CH-Ar), 
2937 (CH-Aliphatic), 2194 (CN), 1649 (C=C) 1466 (C=C), 
1317 (C-N), 1157 (C-C), 1114 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H 4.68 (s, 1H, H-4), 6.4 (d, 1H, J= 2.4 Hz, Ar-H), 
6.49-6.52 (dd, 1H, J= 2.4, 6 Hz, Ar-H), 6.81 (d, 1H, J= 8.7 Hz), 
6.98 (s, 2H, NH2), 7.17-7.20 (m, 1H, Ar-H),  7.26-7.31 (t, 1H, 
J= 7.8 Hz, Ar-H), 7.34-7.35 (t, 1H, J= 1.8 Hz, Ar-H), 7.40-7.43 
(m, 1H, Ar-H), 9.77 (s, 1H, OH). 13C NMR (300 MHz DMSO d6), 
c 55.64, 1012.26, 112.53, 112.94, 120. 46, 121.83, 126.55, 
129.57, 129.88, 129.95, 130.86, 148.79, 149.07, 157.27, 
160.33.  
2-Amino-4-(2-fluorophenyl)-7-hydroxy-4H-chromene-3-
carbonitrile 4l 
IR: (KBr cm-1) 3423 (OH), 3332, 3216 (NH2), 3069 (CH-Ar), 
2904 (CH-Aliphatic), 2189 (CN), 1650 (C=C) 1453 (C=C), 
1297 (C-N), 1148 (C-C), 1110 (C-O-C). H1 NMR (300 MHz 
DMSO –d6): H 4.89 (s, 1H, H-4), 6.40 (d, 1H, J= 2.4 Hz, Ar-H), 
6.47-6.51 (dd, 1H, J= 2.4, 6 Hz, Ar-H), 6.77 (d, 1H, J= 8.4 Hz, 
Ar-H), 6.93 (s, 2H, NH2), 7.11-7.21 (m, 3H, Ar-H),  7.23-7.31 
(m, 1H, Ar-H), 9.75 (s, 1H, OH), BC NMR (300 Hz DMSO d6) 
c 54.62, 102.22, 112.42, 115.58, 115.80, 124.65, 128.73, 
129.45, 129.79, 132.50, 149.07, 157.24, 158.24, 160.59, 
161.49.  
2-Amino-7-hydroxy-4-(3-methoxyphenyl)-4H-
chromene-3-carbonitrile 4m 
IR: (KBr cm-1) 3418 (OH), 3335, 3218 (NH2), 3068 (CH-Ar), 
2943 (CH-Aliphatic), 2191 (CN), 1643 (C=C) 1460 (C=C), 
1346 (C-N), 1152 (C-C), 1119 (C-O-C). H1 NMR (300 MHz 
DMSO –d6): H3.71 (s, 3H, OCH3), 4.58 (s, 1H, H = 4), 6.39 (d, 
1H, J= 2.4, Ar-H), 6.46-6.50 (dd, 1H, J= 2.4, 6 Hz, Ar-H), 6.70-
7.73 (t, 2H, J=6.6 Hz, Ar-H), 6.76-6.79 (m, 1H, Ar-H),  6.82 (d, 
1H, J=8.4 Hz, Ar-H), 6.88 (s, 2H, NH2), 7.19-7.24 (t, 1H, J=7.8, 
Ar-H), 9.71 (s, 1H, OH). 13C NMR (300 MHz DMSO d6) c 
54.99, 56.21, 102.24, 111.53, 112.42, 113.54, 113.68, 119.64, 
120.73, 129.78, 129.92, 148.01, 157.15, 159.40, 160.38 . 
2-Amino-4-(4-ethylphenyl)-7-hydroxy-4H-chromene-3-
carbonitrile 4n 
IR: (KBr cm-1) 3481 (OH), 3345, 3264 (NH2), 3043 (CH-Ar), 
2967 (CH-Aliphatic), 2190 (CN), 1642 (C=C) 1461 (C=C), 
1249 (C-N), 1154 (C-C), 1109 (C-O-C). H1 NMR (500 MHz 
DMSO –d6): H1.13 (t, 3H, J=7.5 Hz CH3), 2.52-2.57 (q, 2H, 
J=7.5 Hz CH3) 2.52-2.57 (q, 2H, J=7.5 Hz, CH2), 4.57 (s, 1H, H-
4) 6.41 (s, 1H, Ar-H), 6.47 (d, 1H, J=8.5 Hz, Ar-H), 6.79 (d, 1H, 
J=8.5 Hz, Ar-H), 6.84 (s, 2H, NH2), 7.06 (d, 2H, J=8 Hz, Ar-H), 
7.12 (d, 2H, J=7.5 Hz, Ar-H), 9.68 (s, 1H, OH), 13C NMR (500 
MHz DMSO d6) c15.99, 28.20, 56.86, 102.60, 112.80, 
114.39, 121.18, 127.75, 128.40, 130.37, 142.46, 144.17, 
149.29, 157.47, 160.66.  
CONCLUSION 
In the present work, with a view of environmentally benign 
consciousness a new class of cyano amino benzopyrans has 
been accomplished in good to excellent yield in short 
reaction time under aqueous medium. The present protocol 
involves mild reaction condition, catalyst free cascade 
reaction and simple workup procedure. The structure of the 
hybrids of product were firmly established by IR, 1H NMR, 
13C NMR, and single crystal X-Ray study.  
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